News

Novo Nordisk has filed another Citizen's Petition with the FDA seeking to block compounding pharmacies in the US from making versions of one of its GLP-1 agonist drugs. The latest attempt focuses ...
Novo Nordisk has abandoned a drug it licensed from KBP Biosciences last year in a deal valued at up to $1.3 billion after it missed the mark in a chronic kidney disease (CKD) trial.
COPENHAGEN (dpa-AFX) - Novo Nordisk A/S (NVO) released a profit for its first quarter that increased from the same period last year The company's earnings totaled DKK29.034 billion, or DKK6.53 per ...
Diddy trial latest: Jurors reach partial verdict but will return to decide on final count The jury has begun deliberations in the trial of Sean "Diddy" Combs. Follow the latest below.
Sean 'Diddy' Combs has been found guilty of two counts of transportation for prostitution but cleared of the more serious charges of sex trafficking and racketeering conspiracy. Follow the latest ...
Complete Novo Nordisk A/S ADR stock information by Barron's. View real-time NVO stock price and news, along with industry-best analysis.